Citius Pharmaceuticals (CTXR) Current Assets (2011 - 2026)
Citius Pharmaceuticals' Current Assets came in at $43.33 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 76.1% from $24.61 million a year earlier and up 36.8% from the prior quarter.
Citius Pharmaceuticals (CTXR) Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals' Current Assets was $27.93 million, up 96.4% from FY2024.
- Current Assets carries a five-year compound annual growth rate of 14.8% (FY2020 to FY2025).
- Going back by fiscal year, Current Assets was $14.22 million in FY2024 (-58.6%), $34.37 million in FY2023 (-22.9%), $44.56 million in FY2022 (-38.8%) and $72.81 million in FY2021 (+420.8%).
- The fiscal Q3 2026 figure represents the highest quarterly Current Assets since fiscal Q4 2022.
- Year-over-year, Current Assets has increased for four consecutive quarters, with growth averaging 28.9% over the last eight quarters.
- The fastest year-over-year change in Current Assets over five years came in fiscal Q4 2021 (growth of 420.8%), and the weakest in fiscal Q4 2024 (a decline of 58.6%).
- Business Quant data shows CTXR's Current Assets at $31.69 million (Q2 2026), $37.95 million (Q1 2026) and $27.93 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Citius Pharmaceuticals | 10.37 Mn | -23.20 Mn | 1.00 Mn | 43.33 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.33 Mn |
| Mar 31, 2026 | 31.69 Mn |
| Dec 31, 2025 | 37.95 Mn |
| Sep 30, 2025 | 27.93 Mn |
| Jun 30, 2025 | 24.61 Mn |
| Mar 31, 2025 | 18.37 Mn |
| Dec 31, 2024 | 18.33 Mn |
| Sep 30, 2024 | 14.22 Mn |
| Jun 30, 2024 | 28.01 Mn |
| Mar 31, 2024 | 21.57 Mn |
| Dec 31, 2023 | 28.21 Mn |
| Sep 30, 2023 | 34.37 Mn |
| Jun 30, 2023 | 41.11 Mn |
| Mar 31, 2023 | 34.90 Mn |
| Dec 31, 2022 | 42.32 Mn |
| Sep 30, 2022 | 44.56 Mn |
| Jun 30, 2022 | 50.83 Mn |
| Mar 31, 2022 | 58.26 Mn |
| Dec 31, 2021 | 67.94 Mn |
| Sep 30, 2021 | 72.81 Mn |
Citius Pharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CTXR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();